Advanced Immunity
Advanced Immunity Benefits
Enhanced Immunity
The unique blend of cannabinoids works synergistically to bolster your immune system. By supporting various pathways, these compounds ensure a robust immune response.
Anti-Inflammatory
CBDA and CBGA are known to reduce inflammation, helping your body fight off pathogens and manage acute and chronic inflammation.
Stress Relief
CBD promotes relaxation and reduces stress, which is vital for maintaining a strong immune response. A calm mind translates to better functioning nervous and immune systems, ready to stay focused and fend off illnesses.
Greater Absorption
Cognitive support, neuroprotective, memory retention, immune boosting, anti-inflammatory, antioxidant, mood boosting.
Boost Your Immunity Naturally
Potent Cannabinoid Combinations
Our Immunity Hemp Softgels are designed to provide an all-natural way to enhance your immune system’s functionality. With a unique blend of cannabinoids and other beneficial ingredients, each softgel supports your body’s defense mechanisms, keeping you healthier throughout the year.
30 Count 50 mg Softgels contain 1500 mgs of active cannabinoids. < 0.3% THC
60 Count 50 mg Softgels contain 3000 mgs of active cannabinoids. < 0.3% THC
Fans of Our Immunity Hemp Softgels Include:
Hemp enthusiasts
Discover the benefits of combined cannabinoids, including the acid forms. These softgels offer a balanced and potent dose of beneficial compounds.
Health-conscious individuals
Opt for a natural, plant-based solution to support your immune system. Avoid synthetic supplements and embrace the power of nature with our carefully crafted formula and potent concentrations.
Wellness seekers
Incorporate a holistic approach to boost immunity and overall health. These softgels fit seamlessly into a wellness-focused lifestyle, supporting both physical and mental health.
Flu Season Defenders
Strengthen your body's defenses during flu and covid season or stressful episodes of traveling. This combination of cannabinoids helps ensure your immune system is ready to tackle seasonal threats.
Fans of Our Immunity Hemp Softgels Include:
Hemp enthusiasts
Discover the benefits of combined cannabinoids, including the acid forms. These softgels offer a balanced and potent dose of beneficial compounds.
Health-conscious individuals
Opt for a natural, plant-based solution to support your immune system. Avoid synthetic supplements and embrace the power of nature with our carefully crafted formula and potent concentrations.
Wellness seekers
Incorporate a holistic approach to boost immunity and overall health. These softgels fit seamlessly into a wellness-focused lifestyle, supporting both physical and mental health.
Flu Season Defenders
Strengthen your body’s defenses during flu and covid season or stressful episodes of traveling. This combination of cannabinoids helps ensure your immune system is ready to tackle seasonal threats.
join us
The Bloom Hemp Community Online
Become part of the Bloom Hemp Community that values health and wellness. Share your experiences and join the conversation on social media with #ImmunityHemp. Connect with others who are also on their journey to better health and share tips and success stories.
Explore the Potential of CBDA & CBGA
Emerging Cannabinoids in Health, Wellness, and Covid-19 Recovery
Cannabidiolic acid (CBDA) and cannabigerolic acid (CBGA) are lesser-known compounds found within the raw cannabis sativa plant, both of which may have exciting effects on the world of health and wellness based on early-stage recent research. In fact, some experts consider these compounds the next frontier when it comes to cannabinoid-based therapy—expanding the potential development of medications that are not only more therapeutically effective but also less likely to cause unwanted side effects and/or long-term dependency than current options [1]. CBDA and CBGA may even protect against the Covid-19 virus and expedite recovery for those infected (11).
CBGA - The Ultimate Cannabinoid
Unlocking the Power of THC, CBD, and Health Benefits
CBGA, or cannabigerolic acid, is a foundational compound of the raw cannabis flower. An enzymatic reaction converts CBGA into several different cannabinoids, earning it the nickname “mother cannabinoid” [2]. It serves as the precursor to three widely found cannabinoids: tetrahydrocannabinolic acid (THCA), cannabichromenic acid (CBCA), and CBDA, all known as acidic cannabinoids. While anecdotal evidence suggests that CBGA may hold potential for various health conditions, further research is necessary to substantiate these claims [3]. Some studies indicate that CBGA may enhance the body’s receptivity to other cannabinoids, aiding in their processing, alongside exhibiting analgesic, anti-inflammatory, antibacterial, and anti-proliferative properties [4]. Through a process called decarboxylation, acidic cannabinoids like CBGA convert into their more well-known forms, including THC and CBD, which are the primary psychoactive components associated with cannabis [5].
CBDA - The Powerhouse Cannabinoid
Superior Absorption and Game-Changing Health Benefits
Cannabidiolic acid, or CBDA, appears in only small quantities in most cannabis plants, although hemp oil is particularly recognized for its higher CBDA content [6]. As a non-intoxicating compound, CBDA is legal in nearly every state. Its bioavailability is notably higher than that of its decarboxylated counterpart, CBD, being absorbed by the body up to 11 times more efficiently when consumed orally [7]. Animal studies suggest that CBDA may be more potent than CBD, not only due to its superior absorption but also because it interacts more effectively within the body to alleviate symptoms such as nausea, vomiting, pain, inflammation, and seizures [8]. Distinct from CBD, CBDA primarily operates by inhibiting the Cox-2 enzyme, which illustrates a different mechanism of action within the endocannabinoid system [9]. Understanding these compounds can lead to significant advancements in therapeutic applications, ultimately contributing to improved health outcomes [10].
Frequently Asked Questions
Yes, our product is meticulously 3rd party lab tested for potency, quality, and purity. We prioritize your health and ensure each batch is made from high-quality, natural ingredients that meet the highest standards possible for hemp supplements.
No, our softgels contain non-psychoactive cannabinoids and will not produce any intoxicating effects. You can enjoy the health benefits without any of the psychoactive side effects.
We recommend consulting with your healthcare provider before adding any new supplement to your routine, especially if you are on medication. Call our Free Nurse Line for more personalized advice based on your health needs @ 970-404-HOPE (4673).
References
- 1. Russo, E.B., 2011. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), pp.1344-1364.
- 2. Gerdeman, G., 2008. Endocannabinoids at the synapse retrograde signaling and presynaptic plasticity in the brain. Journal of Neurophysiology, 99(2), pp.316-320.
- 3. Hanus, L.O., 2009. Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids. Medical Research Reviews, 29(2), pp.213-271.
- 4. Appendino, G., 2011. Antibacterial cannabinoids from Cannabis sativa: A structure-activity study. Journal of Natural Products, 71(8), pp.1427-1430.
- 5. Grotenhermen, F., 2003. Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics, 42(4), pp.327-360.
- 6. Hazekamp, A., 2006. Cannabinoids: an update on the pharmacology and clinical evidence. European Journal of Clinical Pharmacology, 62(1), pp.113-122.
- 7. Mechoulam, R., 2007. Cannabidiol—recent advances. Chemistry & Biodiversity, 4(8), pp.1678-1692.
- 8. Izzo, A.A., 2009. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends in Pharmacological Sciences, 30(10), pp.515-527.
- 9. Takeda, S., 2008. Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis. Drug Metabolism and Disposition, 36(9), pp.1917-1921.
- 10. Pacher, P., 2006. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacological Reviews, 58(3), pp.389-462.
- 11. Van Breemen, R. B., Muchir, A., Denis, H., & Tian, F. (2022). Cannabinoids block cellular entry of SARS-CoV-2 and its emerging variants. Journal of Natural Products, 85(1), 176-184. https://pubmed.ncbi.nlm.nih.gov/35007072/
